Evidence map›Paper›PMID 42161979›Full record

ArticleNature communications2026

omicsGMF: a multi-tool for dimensionality reduction, batch correction and imputation in bulk- and single-cell proteomics.

Alexandre Segers, Cristian Castiglione, Christophe Vanderaa, Lennart Martens, Davide Risso, Lieven Clement

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexandre SegersDepartment of Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0009-0004-2028-7595
Cristian Castiglione *Bocconi Institute for Data Science and Analytics, Bocconi University, Milan, Italy.ORCID http://orcid.org/0000-0001-5883-4890
Christophe Vanderaa *Department of Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0001-7443-5427
Lennart MartensDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0003-4277-658X
Davide RissoDepartment of Statistical Sciences, University of Padova, Padova, Italy. davide.risso@unipd.it.ORCID http://orcid.org/0000-0001-8508-5012
Lieven ClementDepartment of Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium. lieven.clement@ugent.be.ORCID http://orcid.org/0000-0002-9050-4370

Funding

Bijzonder Onderzoeksfonds (Special Research Fund) BOF20/GOA/023Bijzonder Onderzoeksfonds (Special Research Fund) BOF21/GOA/033EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101080544EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101191739Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G010023NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G028821NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G062219NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G071326NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) W005325N
6 · The paper itself

Abstract

The unprecedented speed and sensitivity of mass spectrometry (MS) unlocked large-scale applications of proteomics and even enabled proteome profiling of single cells. However, this fast-evolving field is hindered by a lack of scalable dimensionality reduction tools that can compensate for substantial batch effects and missingness across MS runs. Therefore, we present omicsGMF, a fast, scalable, and interpretable matrix factorization method, tailored for bulk and single-cell proteomics data. Unlike current workflows that sequentially apply imputation, batch correction, and principal component analysis, omicsGMF integrates these steps into a unified framework, dramatically enhancing data processing and dimensionality reduction. Additionally, omicsGMF provides robust imputation of missing values, outperforming bespoke state-of-the-art imputation tools. We further demonstrate how this integrated approach increases statistical power to detect differentially abundant proteins in the downstream data analysis. Hence, omicsGMF is a highly scalable approach to dimensionality reduction in proteomics, that dramatically improves many important steps in proteomics data analysis.

Indexed as

ProteomicsSingle-Cell AnalysisSoftwareAlgorithmsDimensionality ReductionHumansMass SpectrometryPrincipal Component AnalysisProteomeProteome

Identifiers

PMID42161979
PMCPMC13381881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.